Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia - PubMed (original) (raw)
Case Reports
. 1988 Dec 1;319(22):1434-40.
doi: 10.1056/NEJM198812013192202.
Affiliations
- PMID: 3185662
- DOI: 10.1056/NEJM198812013192202
Case Reports
Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia
W H Daughaday et al. N Engl J Med. 1988.
Abstract
We describe a case of recurrent hypoglycemia apparently caused by secretion of insulin-like growth factor II (IGF-II) by a leiomyosarcoma. A 67-year-old woman presented with recurrent severe hypoglycemia and a large mass in the thorax. During hypoglycemia, plasma cortisol was elevated, but insulin and growth hormone levels were low. After resection of a large leiomyosarcoma, the hypoglycemia resolved. After an eight-year remission, both the tumor and symptomatic hypoglycemia recurred. During a second operation a second large tumor was removed, with relief of the patient's hypoglycemia. The tumor contained high concentrations of IGF-II mRNA and 2100 ng of IGF-II immunoreactive peptide per gram. Filtration through a BioGel P-60 gel column established that 77 percent of the IGF-II was present as a larger molecule, demonstrating incomplete processing of the pro-IGF-II peptides. A similar fraction of high-molecular-weight IGF-II was present in the serum, indicating that the tumor was the chief source of IGF-II. The high-molecular-weight IGF-II found in both the tumor and serum was fully reactive with the IGF-II receptor. Radioimmunoassay showed that the concentrations of insulin-like growth factor I (IGF-I) in tumor and serum were low, suggesting feedback inhibition of growth hormone secretion by IGF-II. Eight months after reoperation, plasma concentrations of IGF-I and IGF-II were normal, and high-molecular-weight IGF-II was virtually undetectable. We conclude that the most likely cause of this patient's recurrent hypoglycemia was IGF-II produced by the leiomyosarcoma.
Similar articles
- Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia.
Ron D, Powers AC, Pandian MR, Godine JE, Axelrod L. Ron D, et al. J Clin Endocrinol Metab. 1989 Apr;68(4):701-6. doi: 10.1210/jcem-68-4-701. J Clin Endocrinol Metab. 1989. PMID: 2646313 - Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
Zapf J, Futo E, Peter M, Froesch ER. Zapf J, et al. J Clin Invest. 1992 Dec;90(6):2574-84. doi: 10.1172/JCI116152. J Clin Invest. 1992. PMID: 1281841 Free PMC article. - A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II.
Hino N, Nakagawa Y, Ikushima Y, Yoshida M, Tsuyuguchi M. Hino N, et al. Breast Cancer. 2010 Apr;17(2):142-5. doi: 10.1007/s12282-009-0094-z. Epub 2009 Mar 4. Breast Cancer. 2010. PMID: 19259766 - Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
Fukuda I, Asai A, Nagamine T, Harada T, Tanimura-Inagaki K, Hizuka N, Sugihara H. Fukuda I, et al. Endocr J. 2017 Jul 28;64(7):719-726. doi: 10.1507/endocrj.EJ17-0072. Epub 2017 May 19. Endocr J. 2017. PMID: 28529277 Review. - Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia.
Zapf J. Zapf J. Horm Res. 1994;42(1-2):20-6. doi: 10.1159/000184139. Horm Res. 1994. PMID: 7525443 Review.
Cited by
- Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia.
Chida A, Kawasaki K, Kuramoto J, Hayashi H, Kawahara T, Makiuchi S, So E, Shimizu S, Kishimoto S, Horie S, Saito Y, Shimozaki K, Tsugaru K, Togasaki K, Hirata K, Nishihara H, Kanai Y, Kanai T, Hamamoto Y. Chida A, et al. Oncol Lett. 2024 Sep 26;28(6):568. doi: 10.3892/ol.2024.14701. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39390979 Free PMC article. - A Case of Nonislet Cell Tumor Hypoglycemia Due to Metastatic Salivary Myoepithelial Carcinoma.
Slack MC, Sovich S, Sachs CR, Martinez D, Yu R. Slack MC, et al. AACE Clin Case Rep. 2024 Jun 18;10(5):184-187. doi: 10.1016/j.aace.2024.06.002. eCollection 2024 Sep-Oct. AACE Clin Case Rep. 2024. PMID: 39372824 Free PMC article. - Recurrent Hypoglycemia in a Non-diabetic Female: A Case Study on Doege-Potter Syndrome.
Mohammed SR, Mack N, Ramoutar V, Rampersad J. Mohammed SR, et al. Cureus. 2024 Jun 27;16(6):e63329. doi: 10.7759/cureus.63329. eCollection 2024 Jun. Cureus. 2024. PMID: 39077286 Free PMC article. - Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2.
Potalitsyn P, Mrázková L, Selicharová I, Tencerová M, Ferenčáková M, Chrudinová M, Turnovská T, Brzozowski AM, Marek A, Kaminský J, Jiráček J, Žáková L. Potalitsyn P, et al. Commun Biol. 2023 Aug 19;6(1):863. doi: 10.1038/s42003-023-05239-6. Commun Biol. 2023. PMID: 37598269 Free PMC article. - IGF-2 mediated hypoglycemia and the paradox of an apparently benign lesion: a case report & review of the literature.
Crowley MT, Lonergan E, O'Callaghan P, Joyce CM, Morita M, Conlon N, O'Halloran DJ. Crowley MT, et al. BMC Endocr Disord. 2022 Oct 27;22(1):262. doi: 10.1186/s12902-022-01175-4. BMC Endocr Disord. 2022. PMID: 36303203 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical